KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Capital Expenditures: 2017-2025

Historic Capital Expenditures for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to $10.3 million.

  • Guardant Health's Capital Expenditures rose 146.49% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $39.3 million, marking a year-over-year increase of 93.88%. This contributed to the annual value of $35.1 million for FY2024, which is 71.26% up from last year.
  • As of Q3 2025, Guardant Health's Capital Expenditures stood at $10.3 million, which was up 83.22% from $5.6 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Capital Expenditures peaked at $24.6 million during Q4 2021, and registered a low of $2.4 million during Q3 2023.
  • For the 3-year period, Guardant Health's Capital Expenditures averaged around $6.9 million, with its median value being $5.6 million (2025).
  • Per our database at Business Quant, Guardant Health's Capital Expenditures slumped by 89.08% in 2023 and then soared by 362.96% in 2024.
  • Guardant Health's Capital Expenditures (Quarterly) stood at $24.6 million in 2021, then tumbled by 59.39% to $10.0 million in 2022, then tumbled by 59.23% to $4.1 million in 2023, then soared by 362.96% to $18.9 million in 2024, then spiked by 146.49% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $5.6 million for Q2 2025, and $4.5 million during Q1 2025.